These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. The interaction of clonidine with dopamine-dependent behaviour in rodents. Pycock CJ; Jenner PG; Marsden CD Naunyn Schmiedebergs Arch Pharmacol; 1977 Mar; 297(2):133-41. PubMed ID: 558529 [TBL] [Abstract][Full Text] [Related]
25. Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function. Abdallah L; Bonasera SJ; Hopf FW; O'Dell L; Giorgetti M; Jongsma M; Carra S; Pierucci M; Di Giovanni G; Esposito E; Parsons LH; Bonci A; Tecott LH J Neurosci; 2009 Jun; 29(25):8156-65. PubMed ID: 19553455 [TBL] [Abstract][Full Text] [Related]
26. Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function. Csernansky JG; Glick S; Mellentin J Psychopharmacology (Berl); 1987; 91(4):440-4. PubMed ID: 3108924 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats. Kääriäinen TM; Lehtonen M; Forsberg MM; Savolainen J; Käenmäki M; Männistö PT Basic Clin Pharmacol Toxicol; 2008 Jan; 102(1):50-8. PubMed ID: 17971064 [TBL] [Abstract][Full Text] [Related]
28. Oxytocin-conjugated saporin injected into the substantia nigra of male rats alters the activity of the nigrostriatal dopaminergic system: A behavioral and neurochemical study. Sanna F; Bratzu J; Angioni L; Pina Sorighe M; Cocco C; Argiolas A; Melis MR Brain Res; 2021 Dec; 1773():147705. PubMed ID: 34744015 [TBL] [Abstract][Full Text] [Related]
29. Unilateral lesion of the nigrostriatal pathway decreases the response of interneurons in medial prefrontal cortex to 5-HT 2A/2C receptor stimulation in the rat. Zhang QJ; Wang S; Liu J; Ali U; Gui ZH; Wu ZH; Hui YP; Wang Y; Chen L Brain Res; 2010 Feb; 1312():127-37. PubMed ID: 19948151 [TBL] [Abstract][Full Text] [Related]
30. Ritanserin administration potentiates amphetamine-stimulated dopamine release in the rat prefrontal cortex. Pehek EA; Bi Y Prog Neuropsychopharmacol Biol Psychiatry; 1997 May; 21(4):671-82. PubMed ID: 9194148 [TBL] [Abstract][Full Text] [Related]
31. Aripiprazole differentially affects mesolimbic and nigrostriatal dopaminergic transmission: implications for long-term drug efficacy and low extrapyramidal side-effects. Han M; Huang XF; Deng C Int J Neuropsychopharmacol; 2009 Aug; 12(7):941-52. PubMed ID: 19203411 [TBL] [Abstract][Full Text] [Related]
32. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding. Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767 [TBL] [Abstract][Full Text] [Related]
34. Amperozide and clozapine but not haloperidol or raclopride increase the secretion of oxytocin in rats. Uvnäs-Moberg K; Alster P; Svensson TH Psychopharmacology (Berl); 1992; 109(4):473-6. PubMed ID: 1365865 [TBL] [Abstract][Full Text] [Related]
35. Interaction of the novel antipsychotic drug amperozide and its metabolite FG5620 with central nervous system receptors and monoamine uptake sites: relation to behavioral and clinical effects. Svartengren J; Pettersson E; Björk A Biol Psychiatry; 1997 Aug; 42(4):247-59. PubMed ID: 9270901 [TBL] [Abstract][Full Text] [Related]
36. The selective 5-HT2 receptor antagonist amperozide attenuates 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane-induced inhibition of male rat sexual behavior. Klint T; Dahlgren IL; Larsson K Eur J Pharmacol; 1992 Mar; 212(2-3):241-6. PubMed ID: 1601066 [TBL] [Abstract][Full Text] [Related]
37. Serotonin--dopamine interactions in the nigrostriatal system. Waldmeier PC; Delini-Stula AA Eur J Pharmacol; 1979 May; 55(4):363-73. PubMed ID: 572774 [TBL] [Abstract][Full Text] [Related]
38. The influence of serotoninergic drugs on dopaminergic neurotransmission in rat substantia nigra, striatum and limbic forebrain in vivo. Nissbrandt H; Waters N; Hjorth S Naunyn Schmiedebergs Arch Pharmacol; 1992 Jul; 346(1):12-9. PubMed ID: 1328893 [TBL] [Abstract][Full Text] [Related]
39. Non-cholinergic action of exogenous acetylcholinesterase in the rat substantia nigra. II. Long-term interactions with dopamine metabolism. Hawkins CA; Greenfield SA Behav Brain Res; 1992 Jun; 48(2):159-63. PubMed ID: 1616606 [TBL] [Abstract][Full Text] [Related]
40. Behavioral effects of amylin injected intracerebroventricularly in the rat. Clementi G; Valerio C; Emmi I; Prato A; Drago F Peptides; 1996; 17(4):589-91. PubMed ID: 8804066 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]